Elite Pharmaceuticals Inc (ELTP)

[ARbigguy1]

A little more help with just two minutes of looking -
https://www.investors.com/news/technology/teva-stock-what-we-know-and-do-not-about-the-adderall-shortage/
In 2021, the latest year for which there are data, almost 1.9 billion branded and generic Adderall pills were distributed in the U.S., according to Symphony Health. Teva distributed most of those, at 565 million. At the lowest generic price of 26 cents a pill, that would come to $146.9 million in sales. That doesn't account for the cut drug wholesalers would take of that 26 cents, however. And that's only U.S. sales.

Teva Stock: Sales Likely Higher
Teva's sales are likely higher than that, though, says Joey Mattingly, an associate professor and vice chair for research at the University of Utah's Department of Pharmacotherapy. Brand-name Adderall costs more per pill than its generic counterparts.

Publicly available data shows Veterans Affairs pays $2.61 a pill for the extended-release version of Adderall from Takeda. The agency pays $5.81 per pill for the immediate-release formula from Teva.

"The branded cost is a magnitude higher," Mattingly said in an interview, "15 to 20 times higher."

In December 2022, brand-name Adderall accounted for 17% of prescriptions, according to Iqvia. If that percentage is consistent at Teva, about 96 million of the pills Teva dispensed in 2021 were for the branded version of Adderall, with the remainder being generic. That would come out to nearly $680 million in sales.